Home Cart 0 Sign in  
X

[ CAS No. 298-12-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 298-12-4
Chemical Structure| 298-12-4
Chemical Structure| 298-12-4
Structure of 298-12-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 298-12-4 ]

Related Doc. of [ 298-12-4 ]

Alternatived Products of [ 298-12-4 ]

Product Details of [ 298-12-4 ]

CAS No. :298-12-4 MDL No. :MFCD00006958
Formula : C2H2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :HHLFWLYXYJOTON-UHFFFAOYSA-N
M.W : 74.04 Pubchem ID :760
Synonyms :
Glyoxalic acid;NSC 27785;Oxalaldehydic acid;Formylformic acid
Chemical Name :2-Oxoacetic acid

Calculated chemistry of [ 298-12-4 ]

Physicochemical Properties

Num. heavy atoms : 5
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 13.7
TPSA : 54.37 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.98 cm/s

Lipophilicity

Log Po/w (iLOGP) : -0.09
Log Po/w (XLOGP3) : -0.32
Log Po/w (WLOGP) : -0.73
Log Po/w (MLOGP) : -1.47
Log Po/w (SILICOS-IT) : -0.5
Consensus Log Po/w : -0.62

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -0.03
Solubility : 68.9 mg/ml ; 0.93 mol/l
Class : Very soluble
Log S (Ali) : -0.36
Solubility : 32.3 mg/ml ; 0.436 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 0.93
Solubility : 633.0 mg/ml ; 8.55 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 298-12-4 ]

Signal Word:Danger Class:8
Precautionary Statements:P501-P261-P273-P272-P234-P264-P280-P390-P362+P364-P303+P361+P353-P333+P313-P301+P330+P331-P304+P340+P310-P305+P351+P338+P310-P406-P405 UN#:3265
Hazard Statements:H314-H317-H402-H290 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 298-12-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 298-12-4 ]
  • Downstream synthetic route of [ 298-12-4 ]

[ 298-12-4 ] Synthesis Path-Upstream   1~57

  • 1
  • [ 156-57-0 ]
  • [ 298-12-4 ]
  • [ 16310-13-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1988, vol. 31, # 7, p. 1427 - 1429
[2] Journal of Agricultural and Food Chemistry, 2002, vol. 50, # 19, p. 5394 - 5399
[3] Journal of Medicinal Chemistry, 1978, vol. 21, # 2, p. 165 - 169
[4] Bulletin of the Chemical Society of Japan, 1989, vol. 62, # 10, p. 3247 - 3251
[5] Chemical Communications, 2018, vol. 54, # 12, p. 1501 - 1504
  • 2
  • [ 60-23-1 ]
  • [ 298-12-4 ]
  • [ 16310-13-7 ]
Reference: [1] Bioconjugate Chemistry, 2017, vol. 28, # 2, p. 325 - 329
[2] Chemical and Pharmaceutical Bulletin, 1999, vol. 47, # 8, p. 1180 - 1183
[3] Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1971, vol. 272, p. 1515 - 1517
[4] Comptes rendus hebdomadaires des séances de l'Académie des sciences, 1963, vol. 256, p. 4114 - 4116
  • 3
  • [ 79-19-6 ]
  • [ 298-12-4 ]
  • [ 626-08-4 ]
Reference: [1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1995, vol. 34, # 5, p. 423 - 426
[2] Patent: US5591743, 1997, A,
  • 4
  • [ 614-96-0 ]
  • [ 298-12-4 ]
  • [ 52562-50-2 ]
Reference: [1] Organic and Biomolecular Chemistry, 2018, vol. 16, # 20, p. 3707 - 3710
  • 5
  • [ 95-54-5 ]
  • [ 298-12-4 ]
  • [ 3314-30-5 ]
YieldReaction ConditionsOperation in experiment
81% With hydroxyapatite In water at 52℃; for 6 h; 200 mesh hydroxyapatite powder, 0.008g as catalystUse 52 mL of hot water as solvent,The reaction was carried out with 0.1 mol o-phenylenediamine and 0.11 mol glyoxylic acid as raw materials. The reaction time was 6 hours and the reaction temperature was 52°C.After the reaction is over,Hot filter,Cool the filtrate to 2 °CWhite crystals precipitated,Filtered to obtain crystals,35 °C vacuum drying overnight,That is, benzimidazole-2-formaldehyde 11.9g, yield 81percent,Purity 99.6percent,
Reference: [1] Patent: CN105198819, 2017, B, . Location in patent: Paragraph 0014-0016; 0017-0018; 0019-0020
  • 6
  • [ 95-54-5 ]
  • [ 298-12-4 ]
  • [ 4856-97-7 ]
Reference: [1] Angewandte Chemie - International Edition, 2016, vol. 55, # 42, p. 13340 - 13344[2] Angew. Chem., 2016, vol. 128, # 42, p. 13534 - 13539,6
  • 7
  • [ 98-86-2 ]
  • [ 298-12-4 ]
  • [ 2166-31-6 ]
YieldReaction ConditionsOperation in experiment
15%
Stage #1: at 100℃; for 2 h;
Stage #2: With ammonia In water
Stage #3: With hydrazine hydrate In water at 100℃; for 2 h;
19.6 g (162.95 mmol) of 1-phenylethanone and 5 g (54.32 mmol) of oxoacetate monohydrate were stirred at 100° C. for 2 hours. The reaction solution was then cooled to 40° C., and 20 ml of water and 4 ml of ammonia were added. The mixture was then twice extracted with 50 ml of dichloromethane. 2.64 ml (53.32 mmol) of hydrazine monohydrate were then added to the aqueous phase obtained, and the mixture was stirred at 100° C. for 2 hours. After the reaction, the reaction solution was cooled to room temperature. The precipitated crystals were filtered off with suction, washed with water and dried in a vacuum drying cabinet at 50° C. overnight. This gave 4.3 g (24.97 mmol, 15percent of theory) of the title compound as colorless crystals.LC-MS (method 7): Rt=1.39 min; m/z=173 (M+H)+.1H-NMR (400 MHz, DMSO-d6, δ/ppm): 13.2 (s, 1H), 8.04 (d, 1H), 7.86 (d, 2H), 7.53-7.41 (m, 3H), 7.00 (d, 1H).
15%
Stage #1: at 100℃; for 2 h;
Stage #2: With ammonia In water at 40℃;
Example 41A6-Phenylpyridazin-3 (2H)-one 19.6 g (162.95 mmol) of 1-phenylethanone and 5 g (54.32 mmol) of oxoacetic acid monohydrate were stirred at 100° C. for 2 hours. The reaction solution was then cooled to 40° C., and 20 ml of water and 4 ml of ammonia were added. The mixture was then extracted twice with 50 ml of dichloromethane. 2.64 ml (53.32 mmol) of hydrazine monohydrate were then added to the aqueous phase, and the mixture was stirred at 100° C. for 2 hours. After the reaction, the reaction solution was cooled to room temperature. The precipitated crystals were filtered off with suction, washed with water and dried in a vacuum drying cabinet at 50° C. overnight. This gave 4.3 g (24.97 mmol, 15percent of theory) of the title compound as colorless crystals.LC-MS (Method 4): Rt=1.39 min; m/z=173 (M+H)+.1H-NMR (400 MHz, DMSO-d6, δ/ppm): 13.2 (s, 1H), 8.04 (d, 1H), 7.86 (d, 2H), 7.53-7.41 (m, 3H), 7.00 (d, 1H).
Reference: [1] Patent: US2011/34450, 2011, A1, . Location in patent: Page/Page column 103
[2] Patent: US2012/28971, 2012, A1, . Location in patent: Page/Page column 24-25
[3] Synthesis, 1993, # 3, p. 334 - 342
[4] Medicinal Chemistry Research, 2013, vol. 22, # 6, p. 2553 - 2560
[5] Letters in Drug Design and Discovery, 2013, vol. 10, # 6, p. 507 - 514
[6] European Journal of Medicinal Chemistry, 2016, vol. 108, p. 663 - 673
[7] European Journal of Medicinal Chemistry, 2016, vol. 112, p. 48 - 59
  • 8
  • [ 298-12-4 ]
  • [ 102-51-2 ]
  • [ 55686-93-6 ]
  • [ 55687-11-1 ]
Reference: [1] Journal of the Chemical Society. Perkin Transactions 1, 2001, # 9, p. 978 - 984
  • 9
  • [ 95-83-0 ]
  • [ 298-12-4 ]
  • [ 2427-71-6 ]
Reference: [1] Journal of Medicinal Chemistry, 1996, vol. 39, # 1, p. 158 - 175
[2] Patent: US5541324, 1996, A,
  • 10
  • [ 61-54-1 ]
  • [ 298-12-4 ]
  • [ 16502-01-5 ]
YieldReaction ConditionsOperation in experiment
84%
Stage #1: With hydrogenchloride In water at 20℃; for 0.25 h;
Stage #2: With potassium hydroxide In water at 25℃; for 61.75 h; Inert atmosphere; Cooling; Reflux
Glyoxylic acid monohydrate (12.66 g, 137.6 mmol) was dissolved in 30.0 mL of deionized water. In addition, tryptamine (20.0 g, 124.5 mmol) was mixed with 380.0 mL of deionized water and treated with 3 drops of HCl to assist tryptamine to dissolve in deionized water. The aqueous solution of tryptamine is orange-yellow cloudy at this time. Before tryptamine was completely dissolved in deionized water, the two above aqueous solutions were mixed and stirred about 15 minutes at room temperature. Then, white emulsion is precipitated in the mixed aqueous solution. In addition, KOH (6.8 g) was dissolved in 34.0 mL of deionized water. The aqueous solution of KOH were slowly added in the mixed aqueous solution and then HCl was added until a PH of about 4. The mixture was stirred for one hour at room temperature, and then placed in a refrigerator for 12 hours. After taking out from the refrigerator, a solid was collected by suction filtration. Then, 320.00 mL of deionized water and 60.00 mL of HCl were added and refluxed for 30 minutes. Again, 60.00 mL of HCl was added and refluxed for 15 minutes, then cooled to room temperature. The mixed solution was placed in the refrigerator for 2 days and the precipitate was collected. The precipitate was added in deionized water and heated to 550 so that the precipitate was dissolved and a dark green mixed aqueous solution was obtained. KOH was added in the mixed aqueous solution until a pH of about 12 and then a large amount of light green solid was precipitated. The solid compound 3 ( 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole, 18.19 g, yield: 84percent) was collected by suction filtration. Spectral data as follow: 1H NMR (400 MHz, d6-DMSO): δ 10.67 (s, 1H), 7.34 (d, J=7.6 Hz, 1H), 7.26 (d, J=8.0 Hz, 1H), 6.99 (m, 1H), 6.94-6.93 (m, 1H), 3.86 (s, 2H), 3.08 (br s, 2H), 2.98 (t, J=5.2 Hz, 2H), 2.59 (m, 2H); 13C NMR (100 MHz, d6-DMSO): δ 134.99, 133.68, 126.76, 119.67, 117.60, 116.64, 110.27, 106.42, 42.87, 42.14,
80%
Stage #1: With hydrogenchloride In water at 20℃; for 0.25 h;
Stage #2: With hydrogenchloride; potassium hydroxide In water at 20℃; for 1 h;
Firstly, glyoxylic acid monohydrate (12.66 g, 137.6 mmol) was mixed with and dissolved in deionized water (30.00 mL). Tryptamine (20.0 g, 124.5 mmol) was also mixed and stirred with deionized water (380.00 mL), followed by adding several drops of hydrochloric acid. The two water solutions prepared as above were mixed and stirred for 15 minutes at room temperature, and a large amount of white precipitation was formed. In addition, a potassium hydroxide solution was prepared by dissolving potassium hydroxide (KOH, 6.8 g) in deionized water (34.00 mL). The potassium hydroxide solution was slowly added by drops into the mixed solution containing glyoxylic acid monohydrate and tryptamine, followed by adjusting the pH value of the solution to around 4 by hydrochloric acid. The mixture was stirred for one hour at room temperature and was allowed to stand in a freezer for 12 hours. After taken out from the freezer, the mixture was filtered by suction to collect solid, followed by added with deionized water (320.00 mL) and hydrochloric acid (60.00 mL). After refluxed for 30 minutes, the mixture was added with hydrochloric acid (60.00 mL) and refluxed again for 15 minutes, followed by cooling to room temperature. The mixture was allowed to stand in the freezer for two days for precipitation. The solid was collected and then added with deionized water. The mixture was heated to 165° C. to dissolve the solid and a dark green solution was formed. The pH value of the solution was adjusted to 12 by adding potassium hydroxide and a large amount of ligh green precipitation was formed. The solid was filtered by suction and the compound 3 (18.19 g) was obtained. The yield is 80percent. Spectral data as follow: 1H NMR (400 MHz, d6-DMSO) : δ 6 10.67 (s, 1H), 7.34 (d, J=7.6 Hz, 1H), 7.26 (d, J=8.0 Hz, 1H), 6.99 (m, 1H), 6.94-6.93 (m, 1H), 3.86 (s, 2H), 3.08 (br s, 2H), 2.98 (t, J=5.2 Hz, 2H), 2.59 (m, 2H) ; 13C NMR (100 MHz, d6-DMSO) : δ 134.99, 133.68, 126.76, 119.67, 117.60, 116.64, 110.27, 106.42, 42.87, 42.14, 21.67. The reaction was shown as the following Equation (5).
78%
Stage #1: With hydrogenchloride In water
Stage #2: With potassium hydroxide In water at 20℃; for 1 h;
Example 1; 2-(9-fluorenylmethoxycarbonyl)-2,3,4,9-tetrahydro-1 H-pyrido[3,4- b]indolo-1 -carboxylic acid; Tryptamine (8 g; 50 mmol) was dissolved in H2O (155 ml) by addition of 6M HCI solution. A solution (11 .20 ml) of glyoxalic acid (5.06 g; 68 mmol) in H2O was then added to the reaction mixture.The pH of the reaction mixture was then brought to about 3.5-4 with aqueous 3.5M KOH solution.After stirring for 1 hour at room temperature, the formation of a white precipitate was noted.The reaction mixture was filtered and the precipitate was then washed several times with H2O and acetone. 1 ,2,3,4-Tetrahydro-beta- carboline (8.5 g; yield: about 78percent) was thus obtained.HPLC-MS (MH+ 217); LC-UV purity: 99.3percent (λ = 220 nm) 98percent (λ = 254 nm).
Reference: [1] Patent: US2018/40836, 2018, A1, . Location in patent: Paragraph 0075
[2] Patent: US2017/162794, 2017, A1, . Location in patent: Paragraph 0066
[3] Patent: WO2008/148617, 2008, A1, . Location in patent: Page/Page column 12
[4] Organic Letters, 2014, vol. 16, # 16, p. 4194 - 4197
  • 11
  • [ 343-94-2 ]
  • [ 298-12-4 ]
  • [ 16502-01-5 ]
YieldReaction ConditionsOperation in experiment
73%
Stage #1: With potassium hydroxide In water at 20℃; for 1 h; Inert atmosphere
Stage #2: With hydrogenchloride In water for 1 h; Reflux; Inert atmosphere
General procedure: Commercial tryptamine hydrochloride (4.9 g, 24.9 mmol, 1 eq) and glyoxylic acid (2.6 g, 27.4 mmol, 1.1 eq) were dissolved in 78 mL H2O,and then the solution of KOH (1.38 g, 24.9 mmol, 1 eq) in 6 mL H2O was added dropwise. The mixture was stirredfor 1h and the white precipitate was collected by filtration. The precipitate was dissolved in 78 mL H2O and thesolution was added conc. HCl (6.6 mL) at room temperature. After stirring for one hour under reflux, the solutionwas added 6.6 mL conc. HCl again and stirred for another 0.5 h under reflux. After cooling to r.t., the light-greencrystal was obtained and collected by filtration and then dissolved in 78 mL H2O. The solution was basified by 20percentKOH until pH > 13, and the white precipitate was filtered off and washed with water three times to the titlecompound S16a (3.1 g, 73percent). 1H NMR (400 MHz, DMSO) δ 10.67 (s, 1H), 7.35 (d, J = 7.7 Hz, 1H), 7.27 (d, J =7.9 Hz, 1H), 7.05 – 6.96 (m, 1H), 6.96 – 6.86 (m, 1H), 3.87 (s, 2H), 2.99 (t, J = 5.6 Hz, 2H), 2.60 (t, J = 5.6 Hz,2H). 13C NMR (101 MHz, DMSO) δ 135.9, 134.5, 127.7, 120.6, 118.6, 117.6, 111.2, 107.3, 43.8, 43.1, 22.6.ESI-MS m/z 173 [M + H]+.
Reference: [1] European Journal of Medicinal Chemistry, 2018, vol. 150, p. 30 - 38
  • 12
  • [ 4760-34-3 ]
  • [ 298-12-4 ]
  • [ 20572-01-4 ]
Reference: [1] Journal of the Chemical Society, 1923, vol. 123, p. 1082
  • 13
  • [ 15861-24-2 ]
  • [ 298-12-4 ]
  • [ 17380-18-6 ]
Reference: [1] Organic and Biomolecular Chemistry, 2018, vol. 16, # 20, p. 3707 - 3710
  • 14
  • [ 98546-51-1 ]
  • [ 298-12-4 ]
  • [ 3446-89-7 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 28, p. 8201 - 8205[2] Angew. Chem., 2017, vol. 129, # 28, p. 8313 - 8317,5
  • 15
  • [ 298-12-4 ]
  • [ 102-51-2 ]
  • [ 55687-30-4 ]
  • [ 91192-32-4 ]
Reference: [1] Journal of the Chemical Society. Perkin Transactions 1, 2001, # 9, p. 978 - 984
  • 16
  • [ 826-73-3 ]
  • [ 298-12-4 ]
  • [ 25823-52-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2001, vol. 44, # 17, p. 2707 - 2718
  • 17
  • [ 298-12-4 ]
  • [ 18514-52-8 ]
  • [ 34604-60-9 ]
Reference: [1] Patent: EP1452525, 2004, A1, . Location in patent: Page 15
  • 18
  • [ 298-12-4 ]
  • [ 89641-18-9 ]
  • [ 52606-02-7 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 28, p. 8201 - 8205[2] Angew. Chem., 2017, vol. 129, # 28, p. 8313 - 8317,5
  • 19
  • [ 51471-72-8 ]
  • [ 298-12-4 ]
  • [ 4892-02-8 ]
Reference: [1] International Journal of Chemical Kinetics, 1995, vol. 27, # 5, p. 443 - 452
  • 20
  • [ 298-12-4 ]
  • [ 98480-38-7 ]
  • [ 98453-07-7 ]
  • [ 563-96-2 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1985, # 1, p. 66 - 74
  • 21
  • [ 298-12-4 ]
  • [ 563-96-2 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1959, vol. 24, p. 2532,2539, 2541
[2] Acta Chemica Scandinavica, Series A: Physical and Inorganic Chemistry, 1974, vol. 28, p. 162,167
  • 22
  • [ 7664-93-9 ]
  • [ 7732-18-5 ]
  • [ 298-12-4 ]
  • [ 563-96-2 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1959, vol. 24, p. 2532,2539, 2541
[2] Acta Chemica Scandinavica, Series A: Physical and Inorganic Chemistry, 1974, vol. 28, p. 162,167
  • 23
  • [ 332-51-4 ]
  • [ 371-42-6 ]
  • [ 298-12-4 ]
Reference: [1] International Journal of Chemical Kinetics, 1995, vol. 27, # 5, p. 443 - 452
  • 24
  • [ 17422-33-2 ]
  • [ 298-12-4 ]
  • [ 703-82-2 ]
Reference: [1] Organic and Biomolecular Chemistry, 2018, vol. 16, # 20, p. 3707 - 3710
  • 25
  • [ 6146-52-7 ]
  • [ 298-12-4 ]
  • [ 6625-96-3 ]
Reference: [1] Organic and Biomolecular Chemistry, 2018, vol. 16, # 20, p. 3707 - 3710
  • 26
  • [ 123-38-6 ]
  • [ 298-12-4 ]
  • [ 40834-42-2 ]
Reference: [1] Bulletin des Societes Chimiques Belges, 1992, vol. 101, # 7, p. 627 - 640
[2] Patent: WO2012/7814, 2012, A2, . Location in patent: Page/Page column 21-22
  • 27
  • [ 124-40-3 ]
  • [ 298-12-4 ]
  • [ 1118-68-9 ]
Reference: [1] Tetrahedron Letters, 2003, vol. 44, # 27, p. 5121 - 5124
  • 28
  • [ 298-12-4 ]
  • [ 74213-24-4 ]
YieldReaction ConditionsOperation in experiment
81%
Stage #1: With hydroxylamine hydrochloride In water at 20℃; for 24 h;
Stage #2: With bromine; sodium hydrogencarbonate In dichloromethane; water at 6 - 20℃; for 3.3 h;
To a stirred solution of glyoxylic acid (4) (10 mmol) in H2O(50 mL) was added hydroxylamine hydrochloride (5) (10 mmol)and the solution was stirred for 24 h at room temperature. Next,NaHCO3 (20 mmol) was added carefully followed by CH2Cl2(60 mL). To the two-phase, well-stirred mixture at 6 C was addedBr2 (1 mL) dropwise over 20 min. Upon completion of the additionof Br2, the solution was stirred for 3 h. The organic layer wasseparated and the aqueous layer was extracted with CH2Cl2(50 mL). The combined organic extract was dried (MgSO4), filtered,and evaporated. The residue was crystallized from n-hexane(50 mL). Yield 1.60 g (81percent), mp 65–66 C (lit.19 mp 63–65 C),white crystals.
22%
Stage #1: With hydroxylamine hydrochloride In water for 1 h;
Stage #2: With sodium dihydrogen phosphate monohydrate; bromine; sodium hydroxide In water at 10 - 15℃; Cooling with ice
A solution of glyoxylic acid (37.0 g, 500 mmol) and hydro xylamine hydrochloride (35.1 g, 500 mmol) in water (125 mL) was stirered for 1 h and then sodium hydroxide (50.93 g, 1.27 mmol) added with ice batch cooling. Then a solution of sodium phosphate monobasic H2O (138 g, 1 mol) was added. The reaction mixture was then cooled to 10-15 0C bromine (51.22 mL, 1 mol) was added over 2 h. The resulting reaction mixture was stirred over night at room temperature, then the reaction mixture was dilted with water and extracted with dichloromethane, and the resulting organic phase was dried over sodium sulfate, filtered and evaporated to afford the title compound (22.0 g, 22percent) as an orange solid which was used directly in the next step.
3.5 g
Stage #1: With hydroxylamine hydrochloride In water at 20℃; for 24 h;
Stage #2: With bromine; sodium hydrogencarbonate In dichloromethane; water at 0℃; for 2 h;
Glyoxilic acid (10 g; 0.108 mol) and hydroxylamine hydrochloride (9.4 g; 0.138 mol) were dissolved in water (80 mL) and stirred at rt for 24 hs. NaHCO3 (23.5 g; 0.280 mol) was added in small portions, followed by dichloromethane (100 mL). The two phase system was vigorously stirred and cooled to 0 °C; bromine (30 g; 0.187 mol) was added dropwise. After 2 hs, the phases were separated and the organic layer was washed with water. The solvent was removed in vacuum and the resulting solid was crystallized with petroleum ether, obtaining 3.5 g of 22.
Reference: [1] Tetrahedron Letters, 2015, vol. 56, # 13, p. 1635 - 1637
[2] EJNMMI Research, 2018, vol. 8,
[3] Angewandte Chemie - International Edition, 2017, vol. 56, # 13, p. 3703 - 3707[4] Angew. Chem., 2017, vol. 129, # 13, p. 3757 - 3761,5
[5] Patent: WO2010/127978, 2010, A1, . Location in patent: Page/Page column 51
[6] Tetrahedron Letters, 1984, vol. 25, # 5, p. 487 - 490
[7] Tetrahedron Letters, 1992, vol. 33, # 22, p. 3113 - 3116
[8] Tetrahedron, 2012, vol. 68, # 7, p. 1845 - 1852
[9] Org. Process Res. Dev., 2011, vol. 15, # 5, p. 1073 - 1080
[10] Molecules, 2014, vol. 19, # 6, p. 8661 - 8678
[11] Steroids, 2015, vol. 95, p. 88 - 95
[12] European Journal of Organic Chemistry, 2015, vol. 2015, # 10, p. 2205 - 2213
[13] Angewandte Chemie - International Edition, 2017, vol. 56, # 40, p. 12277 - 12281[14] Angew. Chem., 2017, vol. 129, # 40, p. 12445 - 12449,5
[15] Patent: WO2006/129199, 2006, A1, . Location in patent: Page/Page column 54-55
  • 29
  • [ 107-15-3 ]
  • [ 298-12-4 ]
  • [ 24123-14-6 ]
Reference: [1] Tetrahedron, 1995, vol. 51, # 44, p. 12069 - 12082
[2] Journal of Medicinal Chemistry, 2002, vol. 45, # 14, p. 3032 - 3040
  • 30
  • [ 64-18-6 ]
  • [ 298-12-4 ]
  • [ 2491-15-8 ]
Reference: [1] Journal of the Chemical Society, Chemical Communications, 1982, # 16, p. 927 - 929
  • 31
  • [ 72915-12-9 ]
  • [ 25561-30-2 ]
  • [ 298-12-4 ]
  • [ 354-38-1 ]
  • [ 55982-15-5 ]
Reference: [1] Environmental Science and Technology, 1998, vol. 32, # 16, p. 2357 - 2370
  • 32
  • [ 298-12-4 ]
  • [ 71-36-3 ]
  • [ 105-76-0 ]
  • [ 2050-60-4 ]
  • [ 141-03-7 ]
  • [ 1587-18-4 ]
  • [ 344268-32-2 ]
  • [ 38094-11-0 ]
  • [ 77-94-1 ]
  • [ 105-75-9 ]
  • [ 117538-83-7 ]
  • [ 94086-70-1 ]
Reference: [1] Chemistry and Biodiversity, 2012, vol. 9, # 4, p. 714 - 726
  • 33
  • [ 298-12-4 ]
  • [ 71-36-3 ]
  • [ 105-76-0 ]
  • [ 2050-60-4 ]
  • [ 141-03-7 ]
  • [ 1587-18-4 ]
  • [ 344268-32-2 ]
  • [ 38094-11-0 ]
  • [ 77-94-1 ]
  • [ 105-75-9 ]
  • [ 117538-83-7 ]
  • [ 94086-70-1 ]
Reference: [1] Chemistry and Biodiversity, 2012, vol. 9, # 4, p. 714 - 726
  • 34
  • [ 164461-18-1 ]
  • [ 298-12-4 ]
  • [ 3029-19-4 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 28, p. 8201 - 8205[2] Angew. Chem., 2017, vol. 129, # 28, p. 8313 - 8317,5
  • 35
  • [ 107-20-0 ]
  • [ 298-12-4 ]
  • [ 40636-99-5 ]
Reference: [1] Patent: US2010/204235, 2010, A1, . Location in patent: Page/Page column 5; 27; 28
  • 36
  • [ 15939-85-2 ]
  • [ 6320-02-1 ]
  • [ 298-12-4 ]
Reference: [1] International Journal of Chemical Kinetics, 1995, vol. 27, # 5, p. 443 - 452
  • 37
  • [ 75-05-8 ]
  • [ 298-12-4 ]
  • [ 71-43-2 ]
  • [ 14257-84-2 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1978, vol. <II>, p. 248 - 254
  • 38
  • [ 298-12-4 ]
  • [ 71-36-3 ]
  • [ 105-76-0 ]
  • [ 2050-60-4 ]
  • [ 141-03-7 ]
  • [ 1587-18-4 ]
  • [ 344268-32-2 ]
  • [ 38094-11-0 ]
  • [ 77-94-1 ]
  • [ 105-75-9 ]
  • [ 117538-83-7 ]
  • [ 94086-70-1 ]
Reference: [1] Chemistry and Biodiversity, 2012, vol. 9, # 4, p. 714 - 726
  • 39
  • [ 298-12-4 ]
  • [ 108-95-2 ]
  • [ 1198-84-1 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2008, vol. 47, # 8, p. 1243 - 1248
[2] Tetrahedron Letters, 2003, vol. 44, # 13, p. 2669 - 2672
[3] Agricultural and Biological Chemistry, 1981, vol. 45, # 4, p. 831 - 838
  • 40
  • [ 298-12-4 ]
  • [ 108-95-2 ]
  • [ 1198-84-1 ]
  • [ 1678-71-3 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas-Journal of the Royal Netherlands, 1996, vol. 115, # 7-8, p. 353 - 356
[2] Patent: US6359172, 2002, B1, . Location in patent: Page column 6
[3] Recueil des Travaux Chimiques des Pays-Bas-Journal of the Royal Netherlands, 1996, vol. 115, # 7-8, p. 353 - 356
  • 41
  • [ 298-12-4 ]
  • [ 108-95-2 ]
  • [ 1198-84-1 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas-Journal of the Royal Netherlands, 1996, vol. 115, # 7-8, p. 353 - 356
  • 42
  • [ 298-12-4 ]
  • [ 108-95-2 ]
  • [ 1198-84-1 ]
  • [ 1678-71-3 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1988, vol. 107, # 3, p. 242 - 247
  • 43
  • [ 298-12-4 ]
  • [ 56990-02-4 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 28, p. 8201 - 8205[2] Angew. Chem., 2017, vol. 129, # 28, p. 8313 - 8317,5
  • 44
  • [ 107-15-3 ]
  • [ 298-12-4 ]
  • [ 108-95-2 ]
  • [ 1170-02-1 ]
  • [ 94770-71-5 ]
Reference: [1] Journal of Agricultural and Food Chemistry, 2006, vol. 54, # 12, p. 4355 - 4363
  • 45
  • [ 298-12-4 ]
  • [ 41201-62-1 ]
  • [ 38194-50-2 ]
Reference: [1] Synlett, 2001, # 1, p. 41 - 44
  • 46
  • [ 67-48-1 ]
  • [ 7732-18-5 ]
  • [ 64-18-6 ]
  • [ 107-43-7 ]
  • [ 7664-41-7 ]
  • [ 298-12-4 ]
Reference: [1] Nagasaki med. J., 1959, vol. 34, p. 1179
  • 47
  • [ 95-14-7 ]
  • [ 621-84-1 ]
  • [ 298-12-4 ]
  • [ 124676-19-3 ]
YieldReaction ConditionsOperation in experiment
87% at 120℃; for 2 h; To a 250 ml. flask equipped mechanical stirring, was added 2-oxoacetic acid hydrate (9.2 g,0.1 mol), benzyl carbamate (15.1 g, 0.1 mol) and 1H-benzo[dj[1,2,3jtriazole (9.2 g, 0.1 mol), and toluene (300 mL). The resulting solution was stirred for 2 h at 120 °C in an oil bath. The resulting mixture was filtered and the solid residue was washed with petroleum ether (3x), and dried in vacuo to give 2-(1H-benzo[dj[1,2,3jtriazol-1-yl)-2-(benzyloxycarbonylamino)aceticacid (28.6 g, 87percent) as a white solid that was used without further purification. ESI-MS m/z:327 [M+Hf
87% at 120℃; for 2 h; To a 250 mL flask equipped mechanical stirring, was added 2-oxoacetic acid hydrate (9.2 g, 0.1 mol), benzyl carbamate (15.1 g, 0.1 mol) and 1H-benzo[d][1,2,3]triazole (9.2 g, 0.1 mol), and toluene (300 mL).
The resulting solution was stirred for 2 h at 120° C. in an oil bath.
The resulting mixture was filtered and the solid residue was washed with petroleum ether (3*), and dried in vacuo to give 2-(1H-benzo[d][1,2,3]triazol-1-yl)-2-(benzyloxycarbonylamino)acetic acid (28.6 g, 87percent) as a white solid that was used without further purification. ESI-MS m/z: 327 [M+H]+.
134.9 g for 2 h; Reflux; Dean-Stark A mixture of benzyl carbamate (82.1 g, 0.54 mol), glyoxylic acid monohydrate (50 g, 0.54 mol) and benzotriazole (64.7 g, 0.54 mol) in toluene (2.5 L) was heated at reflux with Dean and Stark water removal for 2 hours. A total of 23 mL of water was collected during the first hour before water evolution ceased. The mixture was allowed to cool to room temperature and the resulting solid filtered and washed with diethyl ether (200 mL). The damp filter cake was dried at 40 °C/50 mmHg overnight to give a cream coloured powder (134.9 g).
Reference: [1] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 5, p. 523 - 527
[2] Patent: WO2017/15449, 2017, A1, . Location in patent: Page/Page column 51
[3] Patent: US2018/193352, 2018, A1, . Location in patent: Paragraph 0205; 0206; 0207
[4] Journal of Organic Chemistry, 1990, vol. 55, # 4, p. 2206 - 2214
[5] Journal of the Chemical Society, Chemical Communications, 1989, # 6, p. 337 - 338
[6] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 21, p. 6389 - 6392
[7] Journal of Medicinal Chemistry, 2006, vol. 49, # 7, p. 2311 - 2319
[8] Patent: WO2004/26843, 2004, A1, . Location in patent: Page 54
[9] Patent: WO2007/34127, 2007, A1, . Location in patent: Page/Page column 27
[10] Patent: WO2016/20698, 2016, A1, . Location in patent: Page/Page column 40; 45
  • 48
  • [ 67-56-1 ]
  • [ 56-40-6 ]
  • [ 298-12-4 ]
  • [ 1035919-25-5 ]
  • [ 5680-79-5 ]
Reference: [1] Tetrahedron, 2008, vol. 64, # 22, p. 5079 - 5084
  • 49
  • [ 598-55-0 ]
  • [ 298-12-4 ]
  • [ 110599-27-4 ]
Reference: [1] Tetrahedron, 1987, vol. 43, # 2, p. 439 - 450
  • 50
  • [ 588-05-6 ]
  • [ 298-12-4 ]
  • [ 91523-50-1 ]
YieldReaction ConditionsOperation in experiment
73% at 4 - 20℃; for 2 h; To a 4° C. solution of Part A compound (3.08 g, 22.5 mmol) in denatured ethanol (70 mL) was added a solution of glyoxylic acid monohydrate (2.0 g, 22 mmol) in ethanol (10 mL) dropwise. Shortly after the addition of glyoxylic acid, a white precipitate formed. The cooling bath was removed, and the reaction mixture was stirred for 2 h at ambient temperature. Filtration gave the title product (3.1 g, 73percent) as a white solid: LC/MS (electrospray, +ions) m/z 194(M+H).
Reference: [1] Journal of Medicinal Chemistry, 1984, vol. 27, # 10, p. 1321 - 1325
[2] Patent: US6649606, 2003, B1, . Location in patent: Page/Page column 38
[3] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 1, p. 47 - 50
[4] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 7, p. 1799 - 1802
  • 51
  • [ 3458-98-8 ]
  • [ 298-12-4 ]
  • [ 91523-50-1 ]
YieldReaction ConditionsOperation in experiment
70% With triethylamine In ethanol at 5 - 20℃; for 1 h; Triethylamine (0.76 mL, 0.55 g, 5.47 mmol) was added to a stirred solution of 3-(2-aminoethyl)phenol hydrochloride (1:1) 25a (1.00 g, 5.76 mmol) in EtOH (26 mL). The mixture was cooled to 5 °C and a solution of glyoxylic acid (0.53 g, 5.76 mmol) in EtOH (6 mL) was added drop wise. The resulting mixture was stirred for 1 hour with gradual warming to room temperature. The resulting solid was filtered and washed with EtOH to provide the title compound (0.78 g, 70percent yield) as an off-white solid. (ES+) m/z (M+1) 193.9. 1H NMR (500 MHz, DMSO-d6) δ ppm 9.35 (br s, 1H) 7.50 (d, J = 8.6 Hz, 1H) 6.60 (dd, J = 8.6, 2.0 Hz, 1H) 6.49 (d, J = 2.0 Hz, 1H) 4.33 (s, 1H) 3.42-3.47 (m, 1H) 3.27-3.34 (m, 1H) 3.06-3.14 (m, 1H) 2.81-2.89 (m, 1H) 2.69-2.78 (m, 1H).
Reference: [1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 19, p. 5833 - 5851
  • 52
  • [ 38449-59-1 ]
  • [ 298-12-4 ]
  • [ 91523-50-1 ]
Reference: [1] RSC Advances, 2018, vol. 8, # 29, p. 16362 - 16369
[2] Journal of Medicinal Chemistry, 1992, vol. 35, # 19, p. 3547 - 3560
  • 53
  • [ 110-62-3 ]
  • [ 298-12-4 ]
  • [ 78920-10-2 ]
YieldReaction ConditionsOperation in experiment
96.3% With morpholine In n-heptane at 40.1 - 41.7℃; for 18 h; Industrial scale Example of industrial batch. All quantities of material were calculated with respect to the glyoxylic acid content of the 50percent w/w glyoxylic acid solution used. (0050) Heptane (1285kg, 1889L, 4.04vol) and morpholine (595L, 601.3kg, 6902mol, 1.09eq) were charged in the reactor. After addition of morpholine, the equipment was rinsed with heptanes (20L, 0.04vol). The solution was stirred at 22 - 23°C for 10min, before being cooled to 4.4°C. (0051) A 50percent aqueous solution of glyoxylic acid (935kg, 6318mol, 1.0eq) was slowly added while maintaining the temperature below 40°C. After addition of glyoxylic acid, the equipment was rinsed with heptanes (20L, 0.04vol). The medium was stirred for 2 hours at a temperature between 30.9 and 23.8°C. Valeraldehyde (706L, 576.8kg, 6697mol, 1.06eq) was then slowly added to the medium while maintaining the temperature below 40°C. (0052) After addition of valeraldehyde, the equipment was rinsed with heptanes (40L, 0.08vol). The reactor contents were heated between 40.1 and 41 .7°C for 18 hours 04 minutes. The medium was then cooled to 22.8°C and an aqueous solution of hydrochloric acid (1 168L, 1.73eq) was added while keeping the temperature between 23.5 and 25.0°C; the medium was stirred for 4 hours. (0053) The medium was allowed to separate and the organic phase was removed. The aqueous phase was washed with heptanes (3x943L, 3x2vol). Diisopropyl ether (1322kg, 1888L, 4.04vol) was added to the aqueous phase followed by solid sodium carbonate (199kg) until a pH value of 0.4 was reached. The medium was allowed to separate and the organic phase was removed. Compound (II) was extracted from the aqueous phase with diisopropyl ether (2x530kg, 2x756L, 2x1 .6vol). The combined organic phases were washed with a 20percent w/w aqueous solution of sodium chloride (944.2kg, 1.6vol). The organic layer was then dried by azeotropic distillation under vacuum at a jacket temperature of maximum 40°C and filtered. The solution was finally concentrated under vacuum below 40°C and a polish filtration through a 10μηι cartridge filter was performed. The total mass of solution (934.9kg) was corrected for the water content (3.7percent) and the DIPE content (3.8percent) to give 864.8kg of compound (II) (6084mol, 96.3percent yield).
92.5% at 10 - 45℃; for 7 h; Large scale 50percent aqueous glyoxylic acid (6kg, 41.1mol) was added to a 50L autoclave, n-heptane (10L), water (3L), cooled to below 10 , it quickly added film (3.57kg, 41.1mol), warmed to 25 , the reaction for 2h, n-valeraldehyde (3.53kg, 41.1mol), completion of the addition was warmed to 45 , reaction 5h, cooled to below 10 , rapid concentrated hydrochloric acid (5L), the reaction 3h, liquid separation, washed with 30percent aqueous sodium bicarbonate n-heptane phase is separated off, and washing with n-heptane phase (3L × 3), the aqueous phase was extracted with diisopropyl ether (6L × 3) with, respectively, diisopropyl ether phase concentration (3L × 2), saturated brine (3L × 1), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to 45 with isopropyl ether, to give a dark yellow product was 5.387kg, HPLC: 98percent pure, a yield of 92.5percent
55% With piperidine hydrochloride In 1,4-dioxane; water for 18 h; Inert atmosphere; Reflux Glyoxilic acid monohydrate (4.55 g, 49.42 mmol) and piperidine hydrochloride (6.30 g, 51.80 mmol) were added to a solution of pentanal (5 mL, 47.02 mmol) in 7:1 dioxane:water (25 mL) under nitrogen. The mixture was heated at reflux for 18 h and, after cooling to room temperature, diluted with 2 M HCl (100 mL) and extracted with diisopropyl ether (3 × 30 mL). The first extract was discharged, while the other two were combined and extracted with 2 M HCl (3 × 30 mL). These three acidic extracts were combined with the reaction mixture, which had been previously diluted with 2 M HCl, and washed with diisopropyl ether, and the whole aqueous layer was extracted with DCM (3 × 80 mL). The DCM extracts were concentrated to give 4a (3.68 g, 55percent) as an oil. 1H NMR (300 MHz, CDCl3) δ 6.00 (s, 1H), 5.84 (t, J = 1.8 Hz, 1H), 4.65 (bs, 1H, exchange with D2O), 2.25–2.52 (m, 2H), 1.52–1.77 (m, 2H), 1.00 (t, J = 7.6 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 172.3, 170.3, 117.2, 99.4, 29.6, 19.9, 13.7. Anal. calcd. for C7H10O3: C, 59.14; H, 7.09. Found: C, 58.98; H, 7.13.
Reference: [1] Patent: WO2017/76738, 2017, A1, . Location in patent: Page/Page column 6-7
[2] Patent: CN106748950, 2017, A, . Location in patent: Paragraph 0064; 0065; 0081; 0082; 0098; 0099; 0115; 0116
[3] Synthetic Communications, 2018, vol. 48, # 1, p. 85 - 90
[4] Patent: WO2011/86565, 2011, A1, . Location in patent: Page/Page column 23-24
[5] Patent: WO2011/86566, 2011, A1, . Location in patent: Page/Page column 24
[6] Patent: WO2012/7814, 2012, A2, . Location in patent: Page/Page column 20-21
[7] Patent: US2012/316361, 2012, A1, . Location in patent: Page/Page column 10
[8] Patent: WO2017/76737, 2017, A1, . Location in patent: Page/Page column 9
  • 54
  • [ 95-47-6 ]
  • [ 96-76-4 ]
  • [ 298-12-4 ]
  • [ 164391-52-0 ]
Reference: [1] Patent: US6359148, 2002, B1, . Location in patent: Page column 40 - 41
  • 55
  • [ 298-12-4 ]
  • [ 104-63-2 ]
  • [ 287930-73-8 ]
YieldReaction ConditionsOperation in experiment
91% Reflux To a 250ml reaction flask was added 50percent glyoxylic acid (67ml, 0.61mol) and tetrahydrofuran (130ml), heated to reflux, was added dropwise N- benzyl ethanolamine (41.5g, 0.27mol) in tetrahydrofuran (20ml) solution, to the reaction complete, the tetrahydrofuran was evaporated, water (170ml), cooled with stirring, to precipitate a solid, ice-water bath was stirred for 30 minutes, filtered and washed with ice water, drying in a yellowish solid, i.e. compounds of formula VII (51.8g, 91percent), mp132 ~ 136 .
Reference: [1] Patent: CN103030668, 2016, B, . Location in patent: Paragraph 0031-0033
[2] Journal of the American Chemical Society, 2003, vol. 125, # 8, p. 2129 - 2135
  • 56
  • [ 20893-30-5 ]
  • [ 298-12-4 ]
  • [ 912368-67-3 ]
YieldReaction ConditionsOperation in experiment
99% With potassium carbonate In methanol for 2 h; Heating / reflux Example 1; 2-phenvI-4-f(3S)-piperidin-3-vIaminolthieno[3,2-c1pyridine-7-carboxamide; Step 1:(2Z)-3-cyano-3-(2-thienyl)acrylic acid; To a stirred solution of 2-thienylacetonitrile (24.8 g,0.20 mol) in MeOH (300 mL) is added glyoxylic acid monohydrate (18.5 g, 0.20 mol) and potassium carbonate (25.5 g, 0.20 mol). The reaction slurry is placed under a nitrogen atmosphere and heated to reflux. After 2h the reaction mixture is cooled to rt and the product is obtained by filtration. The filter cake is washed with a large amount of MeOH and then dried in a vacuum oven overnight to give 43.1 g (99percent) of the title compound as a white crystalline potassium salt. 1H NMR δ 7.95 (d, 3H), 7.75 (d, IH), 7.30 (dd, IH), 7.05 (s, IH), 3.0-4.0 (br s, IH). LCMS (ES, M+H=180, M-H=I 78).
Reference: [1] Journal of Medicinal Chemistry, 2018, vol. 61, # 3, p. 1061 - 1073
[2] Patent: WO2006/106326, 2006, A1, . Location in patent: Page/Page column 53
  • 57
  • [ 540-72-7 ]
  • [ 298-12-4 ]
  • [ 178928-70-6 ]
YieldReaction ConditionsOperation in experiment
89% at 60℃; In a 100 mL reaction flask was added 0.93 gHydrochloride salt of 2- (1-chlorocyclopropyl) -1- (2-chlorophenyl) -3-hydrazinopropan-2-ol, 15 mL of acetonitrile, 0.55 g of a 50percent glyoxylic acid solution and 0.24 g Sodium thiocyanate,Warmed to 60 ° C, after the reaction was added 10mL of water,Adjust pH = 2 or so,The layers were separated, the aqueous phase was extracted with toluene, the organic phases were combined,0.92 g of a solid product was obtained (yield 89percent).
Reference: [1] Patent: CN105949137, 2016, A, . Location in patent: Paragraph 0107; 0108
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 298-12-4 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 6153-56-6

[ 6153-56-6 ]

Oxalic acid dihydrate

Similarity: 0.92

Chemical Structure| 144-62-7

[ 144-62-7 ]

Oxalic acid

Similarity: 0.92

Chemical Structure| 6009-70-7

[ 6009-70-7 ]

Ammonium oxalate monohydrate

Similarity: 0.86

Chemical Structure| 1113-38-8

[ 1113-38-8 ]

Ammonium oxalate

Similarity: 0.86

Chemical Structure| 15750-47-7

[ 15750-47-7 ]

Cerium(III) oxalate xhydrate

Similarity: 0.86

Carboxylic Acids

Chemical Structure| 144-62-7

[ 144-62-7 ]

Oxalic acid

Similarity: 0.92

Chemical Structure| 79-14-1

[ 79-14-1 ]

2-Hydroxyacetic acid

Similarity: 0.77

Chemical Structure| 127-17-3

[ 127-17-3 ]

2-Oxopropanoic acid

Similarity: 0.67

Chemical Structure| 625-45-6

[ 625-45-6 ]

2-Methoxyacetic acid

Similarity: 0.59

Chemical Structure| 617-37-8

[ 617-37-8 ]

2-Ethoxy-2-oxoacetic acid

Similarity: 0.57